Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin's lymphoma (Annals of Oncology (2003) vol. 14 (i17-i20))

J. Vose, V. Sneller

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin's lymphoma (Annals of Oncology (2003) vol. 14 (i17-i20))'. Together they form a unique fingerprint.